The EcN-engineered probiotic system, constructed by Gurbatri et al., can colonize and enrich tumors and release nanobodies that block the immune checkpoints PD-L1 and CTLA-4, thereby stimulating anti-tumor immune responses, which can not only effectively reduce local tumors but also inhibit tumor metastasis [81]. The gene discussed is CD274; the disease is neoplasm.